217 related articles for article (PubMed ID: 12954054)
1. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
Johansson E; Parkinson GN; Denny WA; Neidle S
J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
[TBL] [Abstract][Full Text] [Related]
2. An unusually cold active nitroreductase for prodrug activations.
Çelik A; Yetiş G
Bioorg Med Chem; 2012 Jun; 20(11):3540-50. PubMed ID: 22546205
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel nitroreductases from Bacillus cereus and their interaction with the CB1954 prodrug.
Gwenin VV; Poornima P; Halliwell J; Ball P; Robinson G; Gwenin CD
Biochem Pharmacol; 2015 Dec; 98(3):392-402. PubMed ID: 26415543
[TBL] [Abstract][Full Text] [Related]
4. Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104A.
Prosser GA; Copp JN; Mowday AM; Guise CP; Syddall SP; Williams EM; Horvat CN; Swe PM; Ashoorzadeh A; Denny WA; Smaill JB; Patterson AV; Ackerley DF
Biochem Pharmacol; 2013 Apr; 85(8):1091-103. PubMed ID: 23399641
[TBL] [Abstract][Full Text] [Related]
5. Engineering the
Sharrock AV; McManaway SP; Rich MH; Mumm JS; Hermans IF; Tercel M; Pruijn FB; Ackerley DF
Front Pharmacol; 2021; 12():701456. PubMed ID: 34163368
[TBL] [Abstract][Full Text] [Related]
6. Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility.
Williams EM; Little RF; Mowday AM; Rich MH; Chan-Hyams JV; Copp JN; Smaill JB; Patterson AV; Ackerley DF
Biochem J; 2015 Oct; 471(2):131-53. PubMed ID: 26431849
[TBL] [Abstract][Full Text] [Related]
7. Quinone- and nitroreductase reactions of Thermotoga maritima peroxiredoxin-nitroreductase hybrid enzyme.
Anusevičius Ž; Misevičienė L; Šarlauskas J; Rouhier N; Jacquot JP; Čėnas N
Arch Biochem Biophys; 2012 Dec; 528(1):50-6. PubMed ID: 22982531
[TBL] [Abstract][Full Text] [Related]
8. The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy.
Green LK; Storey MA; Williams EM; Patterson AV; Smaill JB; Copp JN; Ackerley DF
Cancers (Basel); 2013 Aug; 5(3):985-97. PubMed ID: 24202330
[TBL] [Abstract][Full Text] [Related]
9. Reduction of quinones and nitroaromatic compounds by Escherichia coli nitroreductase A (NfsA): Characterization of kinetics and substrate specificity.
Valiauga B; Williams EM; Ackerley DF; Čėnas N
Arch Biochem Biophys; 2017 Jan; 614():14-22. PubMed ID: 27986535
[TBL] [Abstract][Full Text] [Related]
10. Altering the regioselectivity of a nitroreductase in the synthesis of arylhydroxylamines by structure-based engineering.
Bai J; Zhou Y; Chen Q; Yang Q; Yang J
Chembiochem; 2015 May; 16(8):1219-25. PubMed ID: 25917861
[TBL] [Abstract][Full Text] [Related]
11. An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs.
Voak AA; Gobalakrishnapillai V; Seifert K; Balczo E; Hu L; Hall BS; Wilkinson SR
J Biol Chem; 2013 Oct; 288(40):28466-76. PubMed ID: 23946481
[TBL] [Abstract][Full Text] [Related]
12. Rational design of an AKR1C3-resistant analog of PR-104 for enzyme-prodrug therapy.
Mowday AM; Ashoorzadeh A; Williams EM; Copp JN; Silva S; Bull MR; Abbattista MR; Anderson RF; Flanagan JU; Guise CP; Ackerley DF; Smaill JB; Patterson AV
Biochem Pharmacol; 2016 Sep; 116():176-87. PubMed ID: 27453434
[TBL] [Abstract][Full Text] [Related]
13. Studies relating to the synthesis, enzymatic reduction and cytotoxicity of a series of nitroaromatic prodrugs.
Burke PJ; Wong LC; Jenkins TC; Knox RJ; Meikle IT; Stanforth SP
Bioorg Med Chem Lett; 2016 Dec; 26(24):5851-5854. PubMed ID: 27876476
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of reduced MsAcg, a putative nitroreductase from Mycobacterium smegmatis and a close homologue of Mycobacterium tuberculosis Acg.
Chauviac FX; Bommer M; Yan J; Parkin G; Daviter T; Lowden P; Raven EL; Thalassinos K; Keep NH
J Biol Chem; 2012 Dec; 287(53):44372-83. PubMed ID: 23148223
[TBL] [Abstract][Full Text] [Related]
15. The Catalysis Mechanism of
Valiauga B; Bagdžiūnas G; Sharrock AV; Ackerley DF; Čėnas N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673999
[No Abstract] [Full Text] [Related]
16. Structure of RdxA--an oxygen-insensitive nitroreductase essential for metronidazole activation in Helicobacter pylori.
Martínez-Júlvez M; Rojas AL; Olekhnovich I; Espinosa Angarica V; Hoffman PS; Sancho J
FEBS J; 2012 Dec; 279(23):4306-17. PubMed ID: 23039228
[TBL] [Abstract][Full Text] [Related]
17. In silico structure-function analysis of E. cloacae nitroreductase.
Isayev O; Crespo-Hernández CE; Gorb L; Hill FC; Leszczynski J
Proteins; 2012 Dec; 80(12):2728-41. PubMed ID: 22865652
[TBL] [Abstract][Full Text] [Related]
18. Nitroreductase-activated nitric oxide (NO) prodrugs.
Sharma K; Sengupta K; Chakrapani H
Bioorg Med Chem Lett; 2013 Nov; 23(21):5964-7. PubMed ID: 24050886
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa NfsB and nitro-CBI-DEI--a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy.
Green LK; Syddall SP; Carlin KM; Bell GD; Guise CP; Mowday AM; Hay MP; Smaill JB; Patterson AV; Ackerley DF
Mol Cancer; 2013 Jun; 12():58. PubMed ID: 23758947
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of potential prodrugs of DFMO for reductive activation.
Yang Y; Voak A; Wilkinson SR; Hu L
Bioorg Med Chem Lett; 2012 Nov; 22(21):6583-6. PubMed ID: 23031595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
